Similarly, the transwell assays of the effect of Smurf2 on HCC cells migration showed that the number of transmembrane cells was significantly lower in the Smurf2 overexpression groups than in the control groups (Figure 2c and d). The gene discussed is SMURF2; the disease is hepatocellular carcinoma.